What are the common side effects of Vorasidenib and how to deal with them?

Vorasidenib is an oral small molecule drug mainly used to treat low-grade gliomas carrying IDH1 or IDH2 mutations. It is one of the important advances in targeted therapy for specific gene mutations in recent years. Vorsidenib inhibits the activity of isocitrate dehydrogenase (IDH) mutants and reduces the accumulation of D-2-hydroxyglutarate (D-2-HG), thereby delaying tumor growth. Although its efficacy has been confirmed in clinical practice, voxanib may also cause a series of side effects during use. This article will systematically introduce the common side effects of vosidenib and how to deal with it, to help patients and their families better manage the treatment process.
1. Common side effects of vosidenib
According to clinical research data and usage reports, common side effects of vorsidenib mainly include the following categories:
1.Abnormal liver function
One of the common laboratory abnormalities seen with vorsidenib is elevated liver enzymes, including elevated alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Some patients may also experience elevated bilirubin.
2. Fatigue and weakness
Many patients who use vorsidenib report feeling fatigue and decreased energy during treatment. This fatigue is related to the drug's impact on metabolism and the energy-consuming effect of the tumor itself.
3.Headache
As a drug targeting the central nervous system, vorsidenib may cause mild to moderate headaches, which are more obvious in some patients at the beginning of treatment.
4. Nausea, vomiting and loss of appetite
Vorsidenib can cause certain irritation to the digestive system, manifesting as nausea, vomiting, loss of appetite, and sometimes diarrhea or constipation.
5. QT interval prolongation (abnormal electrocardiogram)
A small number of patients may experience QT interval prolongation. Although it is rare, regular ECG monitoring is required during treatment.
6. Cerebral edema or neurological related symptoms
Although voroxinib has lower neurotoxicity than other chemotherapy drugs, individual patients may experience neurological symptoms such as increased cerebral pressure, blurred vision, and epileptic seizures, especially when the tumor response is severe.
7. High blood ammonia or electrolyte imbalance

Some patients may develop metabolic disorders, such as hyperammonemia, hyponatremia, etc., and they need to be vigilant especially when combined with other drugs.

2. How to deal with side effects
For side effects that occur during treatment with vorsidenib, it is recommended to take the following comprehensive response measures:
1. Regularly monitor liver function and blood routine
Liver function and blood indicators should be checked regularly before and during medication. Once elevated transaminases or abnormal bilirubin are found, the dose should be adjusted or treatment suspended under the guidance of a doctor, and hepatoprotective drugs should be used as auxiliary treatment if necessary.
2. Cope with fatigue and adjust the pace of life
Patients should pay attention to rest, avoid overexertion, and maintain a regular schedule. Appropriate light exercise, such as walking or yoga, can help relieve fatigue and improve your mood.
3. Relieve digestive tract discomfort
For symptoms such as nausea and vomiting, you can use antiemetic drugs such as ondansetron as directed by your doctor. It is also recommended to eat small amounts and frequently and avoid greasy and irritating foods. If necessary, gastric mucosal protective agents can be used to reduce stomach discomfort.
4. Monitor electrocardiogram and cardiac function
For patients with underlying cardiac disease, electrocardiogram and electrolyte levels should be evaluated before using vorsidenib. Monitor the QT interval regularly during treatment, and communicate with your doctor promptly if any abnormalities are found.
5. Prevent and respond to nervous system side effects
If patients experience headaches, abnormal vision, or epileptic seizures, brain imaging examinations should be performed promptly. If obvious cerebral edema occurs, hormonal drugs (such as dexamethasone) may need to be used for treatment, and the suspension or reduction of medication may be considered.
6. Strengthen nutritional support and psychological counseling
Maintaining good nutritional intake during treatment will help increase physical strength and resistance. At the same time, emotional management is also very important. It is recommended that patients receive psychological counseling or participate in patient support groups when needed to relieve anxiety and fear.
7. Avoid drug interactions
Vorsidenib may interact with other drugs (such as anti-epileptic drugs, antifungal drugs, etc.). Patients should inform their doctors of all the drugs they are taking and avoid adding or subtracting drugs without authorization.
As a precise targeted therapy drug, vorsidenib has shown a positive effect in delaying the progression of IDH-mutant low-grade glioma. Although its side effects are relatively mild compared with traditional chemotherapy, we still need to pay close attention to the possible adverse reactions. Through regular monitoring, reasonable dosage adjustment, and supportive treatment, most side effects can be effectively controlled. It is recommended that patients maintain close communication with their attending doctors during treatment and provide timely feedback on physical changes to ensure the safety and continuity of treatment.
If any side effects get significantly worse or new symptoms of discomfort appear, you should seek medical attention immediately and do not stop taking the medication or adjust the dose on your own. Scientific and standardized management of side effects can help improve patients' quality of life and treatment compliance.
Reference: https://www.drugs.com/donanemab.html